Perspective Therapeutics (CATX) Interest & Investment Income (2010 - 2026)
Perspective Therapeutics (CATX) posted Interest & Investment Income of $2.2 million for Q1 2026, down 72.36% sequentially from $7.9 million in Q4 2025, and down 7.84% YoY from $2.4 million in Q1 2025.
Perspective Therapeutics (CATX) Interest & Investment Income (2010 - 2026) Analysis & Trends
Perspective Therapeutics has reported Interest & Investment Income for 17 years, with the latest figure at $2.2 million in Q1 2026.
- Quarterly Interest & Investment Income fell 7.84% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.2 million (down 20.61% YoY) and the FY2025 annual result came in at $8.1 million, down 22.83% from the prior year.
- Interest & Investment Income fell to $2.2 million in Q1 2026 per CATX's latest filing, from $7.9 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $10.5 million in Q4 2024 and troughed at -$16000.0 in Q2 2025.
- A 5-year average of $1.8 million and a median of $249000.0 in 2023 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income plunged 88.95% in 2023, then surged 16859.68% in 2024.
- Over 5 years, Interest & Investment Income stood at $561000.0 in 2022, then slumped by 88.95% to $62000.0 in 2023, then soared by 16859.68% to $10.5 million in 2024, then dropped by 24.4% to $7.9 million in 2025, then slumped by 72.36% to $2.2 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $2.2 million, $7.9 million, and $111000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 30.00 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 73.23 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | - |
| 10 | Perspective Therapeutics | 387.89 Mn | 387.89 Mn | - | 2.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.35 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 7.95 Mn |
| Sep 30, 2025 | 111,000.00 |
| Jun 30, 2025 | -16,000.00 |
| Mar 31, 2025 | 2.38 Mn |
| Dec 31, 2024 | 10.52 Mn |
| Dec 31, 2023 | 62,000.00 |
| Sep 30, 2023 | 204,000.00 |
| Jun 30, 2023 | 294,000.00 |
| Mar 31, 2023 | 374,000.00 |
| Dec 31, 2022 | 561,000.00 |
| Sep 30, 2022 | 197,000.00 |
| Jun 30, 2022 | 57,000.00 |
| Mar 31, 2022 | 29,000.00 |
| Dec 31, 2021 | 31,000.00 |
| Sep 30, 2021 | 31,000.00 |
| Mar 31, 2021 | 21,000.00 |
| Dec 31, 2020 | 5,000.00 |
| Sep 30, 2020 | 1,000.00 |